COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,802 | -62.1% | 83,637 | -56.8% | 0.00% | – |
| Q2 2023 | $825,875 | -23.1% | 193,413 | +23.2% | 0.00% | – |
| Q1 2023 | $1,073,443 | -14.2% | 156,936 | -0.7% | 0.00% | – |
| Q4 2022 | $1,250,816 | -16.1% | 158,031 | +1.9% | 0.00% | -100.0% |
| Q3 2022 | $1,491,000 | +34.9% | 155,052 | +1.6% | 0.00% | – |
| Q2 2022 | $1,105,000 | -44.1% | 152,609 | -0.3% | 0.00% | -100.0% |
| Q1 2022 | $1,976,000 | -20.0% | 153,086 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $2,471,000 | +2.6% | 154,788 | +3.3% | 0.00% | 0.0% |
| Q3 2021 | $2,409,000 | +21.9% | 149,864 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $1,977,000 | -25.8% | 142,922 | -21.6% | 0.00% | 0.0% |
| Q1 2021 | $2,664,000 | -13.0% | 182,336 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $3,063,000 | -4.8% | 176,200 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $3,217,000 | +5.8% | 175,404 | +3.0% | 0.00% | 0.0% |
| Q2 2020 | $3,041,000 | +1216.5% | 170,292 | +1096.5% | 0.00% | – |
| Q1 2020 | $231,000 | -14.8% | 14,233 | -5.5% | 0.00% | – |
| Q4 2019 | $271,000 | -4.6% | 15,064 | +7.3% | 0.00% | – |
| Q3 2019 | $284,000 | +10.5% | 14,042 | +20.6% | 0.00% | – |
| Q2 2019 | $257,000 | +96.2% | 11,642 | +21.4% | 0.00% | – |
| Q1 2019 | $131,000 | +59.8% | 9,592 | +5.5% | 0.00% | – |
| Q4 2018 | $82,000 | -38.3% | 9,095 | +12.3% | 0.00% | – |
| Q3 2018 | $133,000 | +30.4% | 8,097 | +11.0% | 0.00% | – |
| Q2 2018 | $102,000 | +30.8% | 7,294 | +2.3% | 0.00% | – |
| Q1 2018 | $78,000 | -15.2% | 7,128 | -31.4% | 0.00% | – |
| Q4 2017 | $92,000 | -33.8% | 10,387 | 0.0% | 0.00% | – |
| Q3 2017 | $139,000 | +3.7% | 10,387 | +11.2% | 0.00% | – |
| Q2 2017 | $134,000 | -22.5% | 9,341 | +12.6% | 0.00% | – |
| Q1 2017 | $173,000 | -14.4% | 8,295 | +15.9% | 0.00% | – |
| Q4 2016 | $202,000 | +83.6% | 7,158 | +74.0% | 0.00% | – |
| Q3 2016 | $110,000 | +66.7% | 4,114 | 0.0% | 0.00% | – |
| Q2 2016 | $66,000 | -19.5% | 4,114 | 0.0% | 0.00% | – |
| Q1 2016 | $82,000 | -18.8% | 4,114 | -6.7% | 0.00% | – |
| Q4 2015 | $101,000 | +11.0% | 4,411 | 0.0% | 0.00% | – |
| Q3 2015 | $91,000 | -26.0% | 4,411 | 0.0% | 0.00% | – |
| Q2 2015 | $123,000 | – | 4,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
| Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
| Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
| TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
| Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
| Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
| Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
| Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |